New insights into the mechanism of action of ebselen, a small-molecule antivirulence agent that reduces disease pathology in a mouse model of Clostridium difficile infection, suggest a different molecular target may be responsible for its efficacy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1126/scitranslmed.aad8926 | DOI Listing |
Publication Analysis
Top Keywords
small-molecule antivirulence
8
antivirulence agent
8
clostridium difficile
8
comment small-molecule
4
agent treating
4
treating clostridium
4
difficile infection"
4
infection" insights
4
insights mechanism
4
mechanism action
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!